EcoDrugPlus

Ensembl ID : ENSOMYG00000054600
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOMYG00000054038
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSOMYG00000054358
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSOMYG00000055657
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000055799
Gene Symbol: -
Cross references: -
345 Possible Orthologues:

Ensembl ID : ENSOMYG00000056125
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSOMYG00000029817
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOMYG00000056416
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSOMYG00000056921
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSOMYG00000057977
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000058091
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000058600
Gene Symbol: -
Cross references: -
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).